Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia

Internal Medicine Journal

Volumn 36, Issue 9, 2006, Pages 571-578

  McNeill, P M ^a   Kerridge, I H ^c   Henry, D A ^d   Stokes, B ^d   Hill, S R ^d   Newby, D ^e   Macdonald, G J ^f   Day, R O ^b   Maguire, J ^d   Henderson, K M ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f Merck Sharp and Dohme (Australia)   (Australia)

Author keywords

Bioethics; Drug industry; Ethics; Medical economics; Medical ethics

Indexed keywords

ARTICLE; AUSTRALIA; DRUG INDUSTRY; FINANCIAL MANAGEMENT; FOOD; GIFT GIVING; HEALTH SURVEY; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL SPECIALIST; PRIORITY JOURNAL; QUESTIONNAIRE; TRAVEL;

ADULT; AUSTRALIA; CONFLICT OF INTEREST; DATA COLLECTION; DRUG INDUSTRY; FEMALE; GIFT GIVING; HUMANS; MALE; MIDDLE AGED; PHYSICIANS;

EID: 33746786455     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01151.x     Document Type: Article

References (32)

1. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J 1993; 149: 1-7.
2. Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement. BMJ 2003; 326: 1189-92.
3. Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: disentanglement. BMJ 2003; 326: 1193-96.
4. Wazana A. Physicians and the pharmaceutical industry. JAMA 2000; 283: 373-80.
5. Griffith D. Reasons for not seeing drug representatives. BMJ 1999; 319: 69-70.
6. Brody H. The company we keep: why physicians should refuse to see pharmaceutical representatives. Ann Fam Med 2005; 3: 82-5.
7. Blumenthal D. Doctors and drug companies. N Engl J Med 2004; 351: 1885-90.
8. Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998; 13: 151-4.
9. Campbell EG, Louis KS, Blumenthal D. Looking a gift horse in the mouth: corporate gifts supporting life sciences research. JAMA 1998; 279: 995-9.
10. Halperin EC, Hutchison P, Barrier RC Jr. Apopulation-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys 2004; 59: 1477-83.
11. Watkins C, Moore L, Harvey I, Carthy P, Robinson E, Brawn R. Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study. BMJ 2003; 326: 1178-9.
12. The Council on Ethical and Judicial Affairs of the American Medical Association. Guidelines on gifts to physicians from industry: an update (Brief version at: American Medical Association, Opinion E-8.061: clarifying addendum to the Opinion 8.061 Gifts to Physicians from Industry [cited May 06]. Available from: URL: http://www.ama-assn.org/ama/pub/category/4001.html). Food Drug Law J 2001; 56: 27-40.
13. Coyle SL (for the Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine). Physician-industry relations. Part 1: individual physicians. Ann Intern Med 2002; 136: 396-402.
14. Coyle SL. Physician-industry relations. Part 2: organizational issues. Ann Intern Med 2002; 136: 403-06.
15. The Australian Medical Association. Doctors' Relationships With the Pharmaceutical Industry. Sydney: The Australian Medical Association; 2002 [cited 2006 May]. Available from: URL: http://www.ama.com.au/web.nsf/doc/WEEN-5GJ7MH
16. The Royal Australasian College of Physicians. Guidelines for Ethical Relationships Between Physicians and Industry, 3rd edn. Sydney: The Royal Australasian College of Physicians; 2006 [cited June 2006]. Available from: URL: http://www.racp.edu.au/public/Ethical_guide_industry.pdf
17. Association of the British Pharmaceutical Industry (ABPI). The Code of Practice for the Pharmaceutical Industry, 2006 January and Guidance on the Code of Practice: Controls on the Promotion of Prescription Medicines in the UK, 2006 February. London: ABPI [cited 2006 May]. Available from: URL: http://www.abpi.org.uk/%2Fpublications%2Fpdfs%2FPMPCA%2Epdf
18. The Pharmaceutical Research and Manufacturers of America (PhRMA). Code on Interactions with Healthcare Professionals. Washington: PhRMA; 2004 January [cited 2006 May]. Available from: URL: http://www.phrma.org/files/PhRMA%20Code. pdf
19. Medicines Australia. Code of Conduct, 15th edn. Canberra: Medicines Australia; 2006.
20. Katz D, Caplan AL, Merz JF. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift giving. Am J Bioeth 2003; 3: 39-46.
21. Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S et al. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations. Intern Med J 2005; 35: 206-10.
22. Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA et al. Medical specialists and pharmaceutical industry-sponsored research: a survey of Australian experience. Med J Aust 2005; 182: 557-60.
23. Henry DA, Doran E, Kerridge IH, Hill SR, McNeill PM, Day RO. Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry. Arch Intern Med 2005; 165: 2493-6.
24. Doran E, Kerridge IK,McNeill PM, Henry DA. Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. Soc Sci Med 2006; 62: 1510-19.
25. Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA. The impact of specialists on prescribing by general practitioners. Med J Aust 2001; 175: 407-11.
26. Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med 1996; 11: 575-83.
27. Wager E. How to dance with porcupines: rules and guidelines on doctors' relations with drug companies. BMJ 2003; 326: 1196-8.
28. Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E et al. Dancing with the porcupine: rules for governing the university-industry relationship. Can Med Assoc J 2001; 165: 783-5.
29. Mather C. The pipeline and the porcupine: alternate metaphors of the physician-industry relationship. Soc Sci Med 2005; 60: 1323-34.
30. The Royal Australasian College of Physicians. Ethical Guidelines in the Relationship Between Physicians and the Pharmaceutical Industry, 2nd edn. Sydney: The Royal Australasian College of Physicians; 1999.
31. Australian Pharmaceutical Manufacturers' Association. Code of Conduct of the Australian Pharmaceutical Manufacturers' Association, 13th edn. Deakin: ACT; 2000.
32. Breen KJ. The medical profession and the pharmaceutical industry: when will we open our eyes? Med J Aus 2004; 180: 409-10.